The Tom70 import receptor on the mitochondrial outer membrane specifically recognizes Hsp90 and Hsc70, a critical step for the import of mitochondrial preproteins, the targeting of which depends on these cytosolic chaperones. To analyze the role of Hsp90 in mitochondrial import, the effects of the Hsp90 inhibitors geldanamycin and novobiocin were compared. Geldanamycin occludes the N-terminal ATP-binding site of Hsp90, whereas novobiocin targets the C-terminal region of the chaperone. Here, novobiocin was found to inhibit preprotein import and, in particular, targeting to the purified cytosolic fragment of Tom70. Hsp90 cross-linking to preprotein and coprecipitation of Hsp90 with Tom70 were both impaired by novobiocin. Overall, novobiocin treatment increased preprotein aggregation, contributing to reduced import competence. In contrast, geldanamycin had no apparent effect on preprotein interactions with Hsp90, formation of preprotein-chaperone complexes, Hsp90 docking onto Tom70, or preprotein association with the outer membrane. Instead, geldanamycin impaired formation of preprotein import intermediates at the outer membrane. This suggests a novel active role for Hsp90 in import steps subsequent to Tom70 targeting. Our results outline the mechanisms of Hsp90 function in preprotein targeting and transport.
The great majority of mitochondrial proteins are encoded in the nucleus, translated by cytosolic ribosomes, and imported into mitochondria by a translocation apparatus located in the mitochondrial outer and inner membranes (1) . The TOM (translocase of the mitochondrial outer membrane) complex contains import receptors that mediate the targeting of preproteins to the membrane and a general import pore complex through which preproteins are translocated. Sorting of preproteins to their appropriate final compartment within the mitochondria is performed by the TIM (translocase of the inner membrane) machinery (2, 3) .
Before import, unfolded or hydrophobic mitochondrial preproteins are bound by cytosolic chaperones, notably Hsc70 (heat shock cognate protein of 70 kDa; the constitutive Hsp70 (heat shock protein of 70 kDa) form in mammals) and Hsp90. Such preproteins include members of the inner membrane metabolite carrier family. The integral membrane Tom70 import receptor contains a tetratricopeptide repeat (TPR) 3 domain similar to those found in several other cytosolic cochaperones of Hsp90 and Hsc70 and provides a specific docking site for the Hsp90 and Hsc70 chaperones. This interaction is thought to be an essential first step in Tom70-dependent preprotein targeting, followed by contact between the preprotein and Tom70 itself (4 -15) . Additional cytosolic proteins, including co-chaperones of Hsp90 or Hsc70 (16 -20) , might also interact with preproteins to further assist import. After targeting to Tom70, preproteins are translocated through the outer membrane via the Tom40 import pore complex. The Tom40 pore also translocates preproteins targeted through the major import receptor Tom20 (21) (22) (23) . After translocation, preproteins of the metabolite carrier family are bound in the intermembrane space by the Tim9-Tim10 complex (24 -30) . Subsequent insertion of carrier proteins into the inner membrane by the Tim22 complex requires the electrochemical gradient across this membrane (31) (32) (33) (34) (35) .
Many aspects of Tom70 function remain unresolved. It is not known how or when cytosolic chaperones transfer preproteins to the TOM proteins. Furthermore, it is still unclear how preproteins progress from Tom70 to translocation or how Tom70 is structurally coordinated with the import pore. Reconstitution experiments suggested that the import pore and Tim9-Tim10 are minimally essential for translocation of a metabolite carrier protein (36) . However, Tom70 was not present in the reconstituted system, so its function in translocation could not be evaluated; in the context of whole mitochondria, Tom70 is clearly important for the import of a variety of proteins (4, 5, 8, 11) . Earlier work on Tom70-mediated import found that the process requires ATP in the cytosol (37, 38) . This has been interpreted as simply allowing cytosolic chaperones to release bound preproteins to the TOM complex, as none of the TOM translocation components are ATPases, including Tom70, the Tom40 pore complex, and Tim9-Tim10 (10, 11, 21, 22, 36) . In this model, cytosolic chaperones dissociate when the prepro-teins are recognized by Tom70. The transfer of preproteins to the translocation pore is then mediated by Tom70 alone. Thus, preprotein import intermediates of ϳ500 kDa observed on outer membranes of yeast mitochondria were postulated to consist solely of preproteins bound to multiple Tom70 molecules (32, 38, 39) . Without an ATP-or energy-dependent component involved, the movement of preproteins from Tom70 to the translocation pore must be essentially stochastic and dependent on the relative affinities for Tom70, the import pore, and Tim9-Tim10 (37) (38) (39) . More recently, we demonstrated a specific interaction between Tom70 and the ATP-dependent chaperones Hsc70 and Hsp90 (9) . We then hypothesized an alternative model in which the chaperones that act in the targeting step might also advance preprotein translocation through their ATP-regulated mechanisms.
The ATPase cycles of both Hsc70 and Hsp90 govern their interactions with substrate polypeptides and are necessary for the chaperones to assist in protein folding. The biochemistry of Hsc70 is relatively well understood: changes in its N-terminal nucleotide-binding domain are transmitted allosterically to its C-terminal substrate-binding domain, which opens and closes around a polypeptide (20) . The biochemical mechanism of Hsp90 is less clear, but it appears to be constitutively homodimerized near its C terminus, and the N-terminal ATPbinding domains are thought to open and close (40 -42) . This conformational change regulates binding of polypeptide, most likely within the central to C-terminal regions of Hsp90 (43) (44) (45) (46) (47) (48) (49) (50) (51) . The ATP-dependent mechanisms of Hsp90 and Hsc70 are used not only for polypeptide folding, but also for a number of cellular processes such as conformational switching and protein transport (52) .
Pharmacological inhibitors of Hsp90 present a unique opportunity to address its mechanism in preprotein import. Because Hsp90 is necessary for the function of many signal transduction proteins and oncoproteins, it has been under intense investigation as a drug target. The benzoquinoid ansamycin antibiotics, including geldanamycin (GA), have been extensively studied for their effects on Hsp90 family chaperones (53) . GA and related compounds occupy the N-terminal ATP-binding pocket of Hsp90, inhibiting the chaperone's ATPase cycle. In cells, GA treatment promotes the proteasomal degradation of proteins dependent on Hsp90 for their folding. As part of this effect, Hsp90 and co-chaperone complexes with substrates are often disrupted (53) (54) (55) (56) . GA has also been shown to impair the Tom70-dependent mitochondrial import of the phosphate carrier (PiC), but its mechanistic effect on the pathway was not explored (9) .
Novobiocin (NB), a coumarin-related compound, targets the C-terminal domain of Hsp90 near the constitutive homodimerization site of the chaperone. The mechanism of NB inhibition is less well understood, but it also appears to cause degradation of Hsp90-dependent proteins in cells. NB has been reported to disassociate Hsp90 complexes with some substrate polypeptides. It is thought to cause conformational changes in Hsp90 that might favor the substrate release state of Hsp90 and also affect its N-terminal conformation, although structural data are still lacking (57-61).
We have used the inhibitors GA and NB to study the mitochondrial import of preproteins mediated by Hsp90. The drugs were tested for effects on the overall efficiency of mitochondrial import and on different steps of preprotein targeting and import. Although NB disrupted preprotein complexes in the cytosol, GA inhibited import at a step following targeting of preprotein to the outer membrane. Interestingly, GA impaired formation of translocation intermediates, suggesting that Hsp90 is important not only for preprotein targeting, but also for the translocation step.
EXPERIMENTAL PROCEDURES
Chemicals-Unless stated otherwise, all chemical reagents were from Sigma or BioShop Canada Inc. (Mississauga, Canada). Restriction enzymes and other recombinant DNA reagents were from New England Biolabs, Invitrogen, and Stratagene. GA was from LC Laboratories (Boston, MA). Untreated rabbit reticulocyte lysate was from Green Hectares (Oregon, WI).
Plasmids-Sequences encoding amino acids 111-608 of human Tom70 (Tom70 Hs-3) and residues 223-352 of human Hop (Hsp-organizing protein p60; TPR2A domain) were in pProExHTa (Clontech) and used as bacterial expression vectors (9, 13) . The sequence encoding bovine PiC was in pGEM-3 (Promega Corp.) (62) ; the sequence encoding bovine ornithine transcarbamylase precursor was in pGEM-3 (from N. J. Hoogenraad); and the sequence encoding murine ANT2 (NM_007451) was amplified by PCR from a cDNA library and inserted into pGEM-4Z (Promega Corp.). The sequence encoding full-length human Tom70 (9) was similarly amplified and inserted into pGEM-4Z. The sequences encoding human Hsp90␣ and rat Hsc70 were in pET15b and pET11a (Novagen), respectively (9, 48) .
Protein Purification-Tom70 Hs-3 and Hop TPR2A were purified as described (9, 13) . Briefly, the expression vectors of the His-tagged proteins were transformed into Escherichia coli BL21(DE3) cells (Stratagene); the cells were grown in terrific broth medium at 37°C; and protein expression was induced with 0.2 mM isopropyl ␤-D-thiogalactopyranoside at 37°C for 2 h. The cells were harvested by centrifugation, resuspended in chilled buffer A (500 mM NaCl, 20 mM KH 2 PO 4 (pH 7.5), and 20 mM imidazole), and lysed by lysozyme treatment and sonication or by cavitation in a French press. The cell debris was removed by centrifugation, and the His-tagged proteins were bound to a nickel-Sepharose high performance column (GE Healthcare) in buffer A. The proteins were eluted with 300 mM imidazole and 20 mM KH 2 PO 4 (pH 7.5). The protein purity was assayed by SDS-PAGE, and the yield was determined by absorbance at 280 nm.
Mitochondrial Import Assays-Rat liver was homogenized, and mitochondria were isolated by centrifugation for import assays as described (63) . The concentration of mitochondria was adjusted to 10 mg/ml in buffer B (250 mM sucrose, 80 mM KOAc, 20 mM HEPES-KOH (pH 7.5), and 5 mM MgOAc 2 ), 10 mM succinate, 1 mM dithiothreitol, 2 mM ATP, and 0.4 mM ADP. Cell-free translations of the preproteins were performed at 30°C for 40 min using the TNT coupled reticulocyte lysate system with SP6 polymerase (Promega Corp.) and [ 35 S]methi-onine (Amersham Biosciences). The reactions were terminated with 1 mM methionine and adjusted to 250 mM sucrose. Rat liver mitochondria were added such that the typical final import reaction contained 25% reticulocyte lysate and 50% mitochondria. The negative control reactions were inhibited with 1 M valinomycin to disrupt the inner membrane potential. For NB treatment, NB was added to the translation reaction to produce a final concentration of 1 mM or the concentration indicated before mitochondria were added. For GA treatment, translation reactions were treated with 18 M GA, and excess GA removed before import reactions as described (9) . The import reactions were incubated at 30°C for 30 min or the indicated times. Half of each sample was digested with 250 g/ml proteinase K at 4°C for 10 min and then with 1 mM phenylmethylsulfonyl fluoride at 4°C for 10 min to stop the digestion, whereas the other half of each sample was untreated. The mitochondria were re-isolated and analyzed by Laemmli SDS-PAGE and autoradiography. Phosphorimaging quantitation was performed with a FujiFilm BAS-1800II analyzer.
Carbonate Extraction-Mitochondria were extracted with high pH as described (74) with modifications. Cell-free translations of full-length human Tom70 were performed with SP6 polymerase and targeted to isolated mitochondria in import reactions as described above. Following targeting, mitochondria were incubated at 0.5 mg/ml in 180 l of 0.1 M Na 2 CO 3 (pH 10.5) at 4°C for 30 min. Samples were layered over 40-l step gradients containing 500 mM sucrose and 0.1 M Na 2 CO 3 (pH 10.5) and then centrifuged at 180,000 ϫ g for 30 min at 4°C in a Beckman Coulter TLA-100 rotor. 200-l supernatant fractions were concentrated by trichloroacetic acid precipitation. Supernatant and pellet fractions were then analyzed by SDS-PAGE.
Coprecipitation Experiments-Cell-free translations of the preproteins and chaperones, as indicated, were performed as described above with SP6 or T7 polymerase. The translations were diluted 20-fold with buffer C (100 mM KOAc, 20 mM HEPES-KOH (pH 7.5), and 5 mM MgOAc 2 ) containing 20 mM imidazole, 0.01% Triton X-100, 2 mg/ml ovalbumin, and 1 mM ATP. The Hsp90 inhibitor GA or NB was added to the reactions at a final concentration of 100 M or 1 mM, respectively, or an equivalent volume of Me 2 SO (1% final concentration) was added as a vehicle control for GA. Tom70 Hs-3 was pre-bound on nickel-Sepharose and added at room temperature for 2 min, followed by 0.1 unit/l apyrase (grade VII, Sigma). The protein complexes were recovered at 4°C for 30 min, and the beads were washed with buffer C containing 20 mM imidazole and 0.1% Triton X-100 and then analyzed by SDS-PAGE. The final reactions contained 5 M Tom70 Hs-3; 5% translation mixture; 100 M GA, 1 mM NB, or 1% Me 2 SO; and nickel-Sepharose beads. The TPR2A binding experiments were as described above except that the final concentration of TPR2A was 10 M.
Cross-linking-Cell-free translations of PiC were performed as described above. Reactions were diluted 16-fold with 25% reticulocyte lysate in buffer C and 1 mM ATP. The Hsp90 inhibitor GA or NB was added to the reactions at a final concentration of 100 M or 1 mM, respectively, or an equivalent volume of Me 2 SO (1% final concentration) was added as a vehicle control for GA. The reactions were incubated at room temperature for 10 min, and 0.1 unit/l apyrase was added. The cross-linker disuccinimidyl suberate (DSS; Pierce) was added at 200 M for 15 min at 4°C. Cross-linking was terminated with 10 mM ethanolamine (pH 8.0) for 15 min at 4°C, and the reactions were resolved by SDS-PAGE. To analyze hemoglobin cross-linking, 25% reticulocyte lysate in buffer C was treated with DSS as described above and analyzed by SDS-PAGE and Coomassie Blue staining. To immunoprecipitate cross-linked products, terminated radiolabeled PiC cross-linking reactions were adjusted to 500 mM NaCl, 20 mM HEPES-KOH (pH 7.5), and 1% SDS and incubated for 10 min at room temperature. Reactions were diluted 5-fold and adjusted to final concentrations of 150 mM NaCl, 20 mM HEPES-KOH (pH 7.5), 1% Triton X-100, and 2 mg/ml bovine serum albumin. A monoclonal antiserum specific for denatured Hsp90 (catalog no. SPA-830, Stressgen Bioreagents) was added together with protein G-Sepharose (Upstate) and incubated for 3 h at 4°C. Beads were washed with phosphate-buffered saline containing 0.1% Triton X-100 and then analyzed by SDS-PAGE.
Gel Filtration-Cell-free translations of PiC or Hsp90 were performed as described above. The reactions were diluted 5-fold in buffer C. The Hsp90 inhibitor GA or NB was added to the reactions at a final concentration of 18 M or 1 mM, respectively, or an equivalent volume of Me 2 SO (1%) was added as a vehicle control for GA. The reactions were incubated at 30°C for 10 min and resolved at 4°C on a Superose 6 10/300 GL column (GE Healthcare) in buffer C. Fractions were collected and analyzed by SDS-PAGE.
Vesicle Flotation-Outer membrane vesicles (OMVs) were prepared from rat liver mitochondria as described (64) . Briefly, mitochondria were swelled at 5 mg/ml in buffer D (10 mM HEPES-KOH (pH 7.5) and 1 mM EDTA) for 30 min at 4°C and then ruptured with a Dounce homogenizer. The preparation was layered over a step gradient containing 3 ml of buffer D with 60% sucrose, 10 ml of 32% sucrose, and 6 ml of 15% sucrose and centrifuged at 27,500 rpm in a Beckman Coulter SW 28 rotor for 1 h at 4°C. The band containing OMVs was collected, and the OMVs were diluted 4-fold in buffer D without sucrose, concentrated by centrifugation, resuspended in buffer B, and stored at Ϫ80°C. Flotation was assayed as described (65) with modifications. Cell-free translations were performed as described above, adjusted to 250 mM sucrose, and incubated with OMVs or an equal volume of buffer B at 30°C for 30 min. Reactions received no treatment or were treated with 0.1 unit/l apyrase, 18 M GA, or 1 mM NB. Reactions were chilled to 4°C, adjusted to 50% sucrose in buffer E (80 mM KOAc, 20 mM HEPES-KOH (pH 7.5), and 10 mM MgOAc 2 ) to a final volume of 120 l, and overlaid with 80 l of buffer E with 35% sucrose and 20 l of 15% sucrose. Gradients were centrifuged at 180,000 ϫ g in the TLA-100 rotor for 30 min at 4°C. The top 40 l and bottom 180 l were analyzed by SDS-PAGE.
Blue Native PAGE-Blue native PAGE (BNP) analysis was performed as described (9, 38) , with modifications. Me 2 SO (1%) was added as a vehicle control, or 18 M GA or 1 mM NB was added after translation. After addition of mitochondria, the GA and NB concentrations were kept constant, and the inner membrane potential was disrupted by 1 M valinomycin, 6 M oligomycin, and 10 M antimycin A. Where indicated, 0.1 unit/l apyrase was added to remove ATP. After proteinase K treat-ment, mitochondria were isolated and solubilized in 10% glycerol, 1% digitonin (Calbiochem), 100 mM ⑀-amino-n-caproic acid, 50 mM KOAc, and 20 mM HEPES-KOH (pH 7.5) at 4°C for 15 min. Insoluble material was separated by centrifugation at 20,000 ϫ g at 4°C for 5 min, Coomassie Blue G-250 (EMD Chemicals) was added to 0.5%, and the samples were resolved on 4 -16.5% acrylamide gradient gels.
RESULTS
Inhibition of Mitochondrial Import-The chaperonedependent Tom70 pathway is thought to mediate the import of hydrophobic preproteins, including those of the metabolite carrier family destined for the inner membrane (11) . GA has been shown to partially but significantly inhibit the import of such preproteins, including PiC in vitro and in cultured cells (9) . To gain further mechanistic insight into the role of Hsp90 during import, the effect of NB on the import of PiC was tested. Radiolabeled PiC was generated by cell-free translation and imported into isolated rat liver mitochondria in the absence or presence of 1 mM NB. The extent of import was monitored by the appearance of the mature proteolytically processed form of PiC (62), and the amount of mature PiC protected from added protease was determined (Fig. 1A , compare lanes 2 and 4). As a negative control, import was abolished when the potential across the inner membrane was destroyed with valinomycin, an ionophore (Fig. 1A , compare lanes 4 and 5). Strikingly, NB greatly diminished import, although inhibition was not as absolute as that caused by valinomycin (Fig. 1A , compare lanes 4 and 8). With this assay, the effect of NB on preprotein import was investigated over a range of drug concentrations and quantified by the appearance of the protease-protected mature form of PiC (Fig. 1B, upper panel) . The half-maximal inhibitory concentration of NB was ϳ300 M (Fig. 1B, lower panel) . This level is in line with measurements using other Hsp90-dependent systems, in which half-maximal inhibition is typically observed between 200 M and 1 mM (57-61). The actual affinity of binding between NB and Hsp90 has not yet been measured, but has been proposed to be in this range. In an additional experiment, the kinetics of import upon NB inhibition were tested in a time course experiment. PiC is normally imported at a relatively constant rate over 15 min, and NB markedly reduced this rate, although the curve still remained linear (Fig. 1C) . This suggested that import was inhibited continuously throughout the assay, rather than being delayed or abruptly terminated, and was consistent with previously observed behavior upon dysfunction of chaperones or the import apparatus (4 -11). For a mechanistic comparison with NB, the effect of GA on import was also studied. Both drugs have been demonstrated to impair Hsp90 function, although much lower concentrations of GA are typically required: 0.5-10 M GA in live cells or 10 -100 M GA in vitro (48, (53) (54) (55) (56) (57) (58) (59) (60) (61) . Such concentrations agree with the ϳ2 M affinity of GA for Hsp90 measured in vitro (53) . To compare the drugs in the mitochondrial import assay, we used 1 mM NB (based on Fig. 1B ) and 18 M GA, which was found to be sufficient for complete Hsp90 inhibition in our previous work (9, 48) . In addition to PiC, the import of a structurally related inner membrane carrier protein, the adenine nucleotide transporter (ANT) (66) , was tested, along with ornithine transcarbamylase, a matrix protein largely dependent on the Tom20 receptor for its import (16) . ANT is not processed upon import, and its import was monitored by protection of the fulllength protein from protease; ornithine transcarbamylase import was quantified by the appearance of the protease-protected mature form with its leader peptide removed (data not shown). NB inhibited the import of PiC to Ͻ20% of the control, as shown above. The import of ANT was also inhibited by NB to ϳ35% of the control, whereas ornithine transcarbamylase import was significantly less inhibited to ϳ65% of the control ( Fig. 2A) . Consistent with previous results (9) , GA inhibited the import of PiC to ϳ60% of the control. GA reduced the import of ANT more moderately to ϳ70% of the control and had no significant effect on the import of ornithine transcarbamylase ( Fig.  2A) . In time course experiments, the import of ANT was inhibited continuously through the assay by NB, similar to the import of PiC (Fig. 1C) . Overall, the import of the two carrier proteins PiC and ANT was more sensitive to Hsp90 inhibition than that of ornithine transcarbamylase, consistent with a greater dependence on the chaperone-Tom70 import pathway. Moreover, NB was a markedly stronger inhibitor of PiC and ANT import than was GA.
To address concerns regarding the specificity of NB, mitochondria were pretreated with 1 mM NB and then re-isolated, and import was assayed in the absence of the drug. The import of the preproteins tested was not significantly diminished by NB pretreatment (data not shown), ruling out drastic effects of the drug on the mitochondria such as disruption of the membrane potential. As an additional test of specificity, the effect of Hsp90 inhibitors on signal-anchor integration into the mitochondrial outer membrane was analyzed. Targeting of signalanchor proteins is thought to be independent of the Tom20 and Tom70 receptors, but still requires a functional Tom40 import pore. Tom70 itself follows the signal-anchor route (75) . So, cellfree translated Tom70 was targeted to mitochondria in the presence of the Hsp90 inhibitors, and its membrane integration was tested by resistance to high pH (Na 2 CO 3 ) extraction. Under these conditions, peripherally bound proteins can be separated from integral membrane proteins by centrifugation (74) . In all cases, the great majority of Tom70 resisted extraction (Fig. 2B) , suggesting that it was properly integrated, regardless of the presence of NB or GA during the integration reaction. These results indicate that the inhibition of import observed in Fig. 2A was most likely due to effects of the drugs on their known target, Hsp90, rather than on the translocation machinery within the mitochondrial membrane.
The difference in strength between GA and NB inhibition was intriguing and suggested that the drugs work by different modes of action. Both inhibitors are known to be specific for Hsp90 under the conditions used. Although higher concentrations of NB have been found to cause additional effects on Hsc70 (59), the NB concentration of 1 mM used in our assays was well below the 10 mM level above which loss of specificity was observed. The specificity of GA for Hsp90 family chaperones has been firmly established (53) . We therefore hypothesized that the difference between the inhibitors may be related to their mechanisms, perhaps acting on different steps of the import process. Accordingly, a series of experiments were performed to more closely determine the means of inhibition of each drug.
Inhibition of Targeting to Tom70-Targeting of preproteins onto Tom70 can be reconstituted using the purified cytosolic fragment of the receptor. In a previously established assay, radiolabeled PiC was generated by cell-free translation and incubated with a purified N-terminally His-tagged Tom70 cytosolic fragment (Tom70 Hs-3) and recovered using nickelSepharose (9). PiC was clearly recovered with the Tom70 fragment relative to the control with nickel-Sepharose alone (Fig.  3A, upper panel, lanes 2 and 3) . The drug vehicle control Me 2 SO had no effect in this experiment and the other experi- 5 and 6) , or 1 mM NB (lanes 7 and 8) . Re-isolated mitochondria were extracted with Na 2 CO 3 (pH 10.5) and separated into supernatant (S) and pellet (P) fractions by ultracentrifugation.
ments shown below (Fig. 3A, upper panel, lane 4) . Notably, GA had little detectable effect on the amount of PiC recovered (Fig.  3A, upper panel, lane 5) . In contrast, NB reduced PiC binding to ϳ20% of the control, almost to the level of the negative control (Fig. 3A, upper panel, lane 6) . Neither drug interfered with binding of the Tom70 cytosolic fragment to the nickel-Sepharose beads as determined by total protein staining (data not shown). So, preprotein targeting to Tom70 appears to be blocked by NB, but not significantly by GA. Previous results demonstrated that docking of Hsp90 (or Hsc70) onto human Tom70 is necessary for preprotein contacts with the import receptor (9), and NB must therefore block targeting by some action on Hsp90.
NB may inhibit preprotein targeting by preventing Hsp90 docking onto Tom70 or by disrupting preprotein binding by Hsp90. It was unclear from previous reports what the effect of NB on the Hsp90 interaction with the Tom70 TPR clamp domain should be. NB was first reported not to disrupt interactions between Hsp90 and the TPR domain co-chaperones FKBP52 (FK506-binding protein of 52 kDa) and protein phosphatase-5 (15) . However, a recent report suggested that, under certain conditions, differential displacement of FKBP52 is observed (61) . To investigate whether this is the case for Tom70, the direct interaction between Tom70 and Hsp90 was examined. For accuracy of quantitation, radiolabeled Hsp90 generated by cell-free translation was used to represent the total Hsp90 population in the lysate and was recovered with the Tom70 Hs-3 fragment on nickel-Sepharose (9, 48). The recovery of Hsp90 was partially reduced by NB treatment to ϳ60% of the control (Fig. 3B, upper panel, lanes 3 and 6) . Although significant, the NB effect was milder than the marked inhibition by NB of preprotein targeting to Tom70 (Fig. 3A) and of overall mitochondrial import (Fig. 2A) . This discrepancy was addressed in the experiments described below. In contrast to NB, GA had no effect on the interaction of Hsp90 with Tom70 (Fig. 3B, upper panel, lane 5) .
Both Hsp90 and Hsc70 can dock onto Tom70 to support preprotein targeting and import (9) . As a control for the specificity of NB action, radiolabeled Hsc70 was similarly assayed for binding to the Tom70 cytosolic fragment. As expected, neither drug significantly inhibited the Hsc70-Tom70 interaction (Fig. 3C) .
To investigate whether the NB disruption of the Hsp90-Tom70 interaction represents a more general effect of the drug, binding of Hsp90 to the TPR clamp co-chaperone Hop was assayed. Structural studies determined previously that the central TPR2A domain of Hop is responsible for binding the C-terminal peptide sequence of Hsp90 (13) . Radiolabeled Hsp90 was thus tested for interaction with the purified His-tagged TPR2A domain of Hop. Similar to the Hsp90-Tom70 interaction, GA had no discernible effect on Hsp90 binding to TPR2A, whereas NB partially reduced binding to ϳ50% of the control (Fig. 3D) . These results suggest that the partial disruption of Hsp90 binding to TPR domain co-chaperones may be a typical effect of NB. The incomplete nature of the NB effect may be consistent with the variable results reported for the Hsp90-FKBP52 interactions (61). However, disruption of co-chaperone binding by NB may not completely account for the overall effect of the drug on preprotein targeting and import.
Inhibition of Preprotein Binding by Hsp90-It is possible that NB interferes with the direct interaction between Hsp90 and substrate polypeptide, in addition to the interactions between Hsp90 and co-chaperones. To assess preprotein binding by chaperones, radiolabeled PiC generated by cell-free translation was cross-linked to proteins in the reticulocyte lysate with the bifunctional amine-reactive agent DSS under physiologic ionic strength conditions. Upon addition of the cross-linker, several high molecular mass bands appeared (Fig. 4A, left panel, lanes 1  and 2) . The darkest of these were a cluster of three bands at ϳ160 kDa (Fig. 4A, left panel, arrow a) , and additional pairs of bands were observed at ϳ140 kDa (arrow b) and 130 kDa (arrow c). It is most likely that the bands represented the preprotein covalently linked to one or more chaperones in the lysate. However, it was difficult to judge the identity of the cross-linked species based on the apparent molecular masses of the bands. Subtraction of the molecular mass of the preprotein (37 kDa) suggested that it was linked to proteins Ն100 kDa in size, which is inconsistent with the expected size of the Hsp90 and Hsc70 chaperones. To determined whether some of these bands represented covalently linked Hsp90, cross-linking reactions were denatured to abrogate all noncovalent protein-pro- tein interactions and immunoprecipitated using an antibody specific for non-native Hsp90. The anti-Hsp90 antibody recovered bands corresponding to the slowest migrating cross-linked species (Fig. 4B, lane 6, arrow a) , identifying them as Hsp90 adducts. Because of the denaturing conditions used for immunoprecipitation, the adducts must represent preprotein that was in direct contact with Hsp90 during the cross-linking, ruling out interactions mediated by a third factor. The misleading apparent molecular masses of the Hsp90 adducts were most likely due to aberrant migration of the adducts upon denaturing electrophoresis. The other cross-linked bands observed may correspond to Hsc70 and/or other chaperones interacting with the preprotein in ternary complexes stabilized by Hsp90.
The effects of GA and NB treatment on preprotein crosslinking to Hsp90 were then assayed. The effects of GA on substrate-Hsp90 complexes have been well documented. GA prevents the ATP-dependent dissociation of Hsp90 from substrate polypeptide under physiologic ionic strength conditions, but weakens the substrate-Hsp90 interaction such that, under more stringent conditions (high ionic strength/high detergent), the interaction is lost (40 -42) . In agreement with this, GA did not affect the intensity of the cross-linked species (Fig. 4A, left   panel, lane 6) , as the cross-linking was performed under the moderate ionic strength of the translation reaction (80 mM KOAc). However, NB caused a clear reduction in intensity of the Hsp90-cross-linked species (Fig. 4A, left panel, lane 8) . Quantitation revealed that formation of the adduct was reduced to Ͻ60% of the control (Fig. 4A, right panel) , although it was not abolished completely. This indicated that, as well as interfering with Tom70 interactions with Hsp90 (Fig. 3B) , NB also diminished direct interactions of Hsp90 with the preprotein. Our results extend earlier observations that NB can disrupt Hsp90 complexes with steroid receptors and kinases (59, 60) by measuring a reduction in actual intermolecular contact.
To confirm the specificity of NB action, cross-linking of hemoglobin in the reticulocyte lysate was analyzed by total protein staining. Native hemoglobin is an ␣ 2 ␤ 2 -tetramer; and under the conditions used, species corresponding to covalently linked hemoglobin dimers were observed only upon addition of cross-linker (Fig. 4C, lane 2, arrow d) . Neither GA nor NB affected the appearance of the cross-linked species (Fig. 4C,  lanes 6 and 8) . Therefore, NB did not interfere with the crosslinking reaction itself or with protein-protein interactions in general. These results indicate that the loss of preprotein crosslinking to Hsp90 upon NB treatment (Fig. 4A ) was due to a specific effect on Hsp90.
Disruption of Cytosolic Preprotein-Chaperone ComplexesBefore import, the preprotein PiC is maintained in the cytosol by a high molecular mass complex containing Hsp90 and Hsc70. Upon analysis by gel filtration chromatography, cellfree translated PiC elutes mostly in a peak with an apparent size of ϳ550 kDa (9) . This is similar in size to other substrate-Hsp90 complexes, e.g. those formed with the glucocorticoid receptor (18) . Because the reduction in preprotein-Hsp90 cross-linking caused by NB was partial, it was possible that other chaperones would compensate to maintain solubility of the preprotein. In particular, Hsc70 was expected to have a major role in maintaining solubility and targeting to Tom70 of preproteins. So, to determine the overall effect of Hsp90 inhibitors on cytosolic preprotein complexes, the gel filtration profiles of the preprotein were tested after different treatments.
Control reactions of radiolabeled PiC generated by cell-free translation in reticulocyte lysate produced the expected gel filtration profile, with the preprotein eluting mostly in a broad peak between the 440-and 669-kDa size markers on a Superose 6 column (Fig. 5A, upper panel) . GA treatment prior to gel filtration analysis did not greatly alter the elution of the preprotein (Fig. 5A, middle panel) . This is consistent with the crosslinking data (Fig. 4A ) and previous results, as the chromatography was performed under the same physiologic ionic strength conditions. After NB treatment, a similar peak of preprotein centered ϳ550 kDa was observed, but significant amounts of the preprotein now eluted in earlier fractions without forming clear peaks (Fig. 5A, lower panel) . Preprotein was even detected eluting in the void volume of the column, which had an exclusion limit of ϳ50 MDa. The amount of preprotein eluting in earlier fractions, with apparent molecular sizes larger than ϳ2 MDa, was estimated to be 36% of the total preprotein following NB treatment. This compared with 14% of the preprotein in the same size range in the control profile and with 7.3% of the pre- 2) and then denatured and diluted into nondenaturing buffer, followed by immunoprecipitation using preimmune serum (pre-imm; lanes 3 and 4) or antiserum specific for Hsp90 (␣Hsp90; lanes 5 and 6). The positions of unmodified PiC (solid arrow) and the high molecular mass band (arrow a) are indicated. Note that a 4-fold longer exposure of lanes 3-6 is shown (boxed) relative to that of lanes 1 and 2. C: total reticulocyte lysate was treated with DSS as described for A and analyzed by SDS-PAGE and Coomassie Blue total protein staining. The positions of unmodified hemoglobin (Hg; solid arrow) and a cross-linked product (arrow d) are indicated. The positions of molecular mass markers (shown in kilodaltons) are indicated.
protein after GA treatment (Fig. 5A) . It seems most likely that NB prevented preprotein interaction with Hsp90, leading to aggregation of the preprotein. This would explain the apparent heterogeneity and very large sizes of preprotein complexes in the early fractions. It appears that the other chaperones present in the cytosol could not completely compensate for loss of Hsp90 activity due to NB inhibition.
The multiple effects of NB on Hsp90 (inhibition of co-chaperone and substrate polypeptide binding) raised the concern that Hsp90 was being grossly disrupted. Also, it has been proposed that coumarin-derived antibiotics such as NB could affect the C-terminal dimerization of Hsp90 (60, 61) . To investigate these possibilities, the gel filtration behavior of Hsp90 itself was analyzed after different treatments. Hsp90 was radiolabeled by cell-free translation and, in the absence of drug treatment, eluted in a characteristic peak at ϳ500 kDa (Fig. 5B,  upper panel) . This was close to the known elution profile of purified Hsp90 and of Hsp90 in typical cell lysates (41) ; because of the extended structure of Hsp90, binding of additional proteins causes relatively minor changes in the apparent molecular radius. Treatment with GA or NB before chromatography did not change the Hsp90 elution profile substantially (Fig. 5B) , ruling out obvious effects such as aggregation of the chaperone. Also, if NB disrupted the Hsp90 homodimer, the disruption was reversible upon separation of Hsp90 from the drug over the column.
Taken together, these data suggest a dual mechanism of NB action on Hsp90-mediated preprotein targeting to mitochondria. First, NB reduces preprotein interactions with Hsp90, resulting in its aggregation and incompetence for import. Second, NB impairs Hsp90 docking onto the Tom70 receptor. Although both of these effects are partial, in combination, they result in a relatively severe block in Tom70 targeting and mitochondrial import of preproteins dependent on Hsp90.
Inhibition of Preprotein Translocation-It was remarkable that, despite the inhibition of preprotein import by GA, this drug had virtually no effect in the other assays described above. GA did not prevent targeting of PiC onto Tom70 (Fig. 3A) , suggesting that it impaired the import of PiC at a step associated with the mitochondrial outer membrane. The mode of GA inhibition on the outer membrane was therefore investigated more closely.
Although Tom70 is thought to be the primary membraneassociated receptor responsible for the targeting of inner membrane proteins such as PiC, other outer membrane proteins might still contribute to the targeting step. In humans and other mammals, orthologs of the well characterized yeast TOM proteins Tom20 and Tom22 have been identified (67, 68) . Also, the membrane-integrated protein metaxin appears to play a supplementary role in import (69) . It is possible that Hsp90 interacts with some of these proteins in addition to Tom70 and that GA diminishes these supplementary interactions. To analyze the overall targeting of preprotein to the outer membrane translocation apparatus, binding of PiC to isolated OMVs was tested. Radiolabeled PiC generated by cell-free translation was incubated with OMVs prepared from rat liver mitochondria, and vesicles were separated from cytosolic components by flotation in density gradients. The preprotein was detected in the top fraction of the gradients when OMVs were added, but not in their absence (Fig. 6A, compare lanes 2 and 3) . GA treatment did not block association of the preprotein with vesicles; and furthermore, removal of ATP with apyrase also had no effect on preprotein targeting (Fig. 6A, lanes 4 and 5) . As expected from the results of Figs. 2 and 3 , NB inhibited association of the preprotein with OMVs (Fig. 6A, lane 6) . These results indicate that, unlike NB inhibition of import, GA inhibition must occur subsequent to targeting of preprotein to the outer membrane. There is also no evidence for an additional interaction site for Hsp90 on the membrane other than Tom70. Finally, ATP cycling by chaperones, including Hsp90, was not necessary for preprotein targeting to the OMVs.
In experiments with Saccharomyces cerevisiae mitochondria, at least two steps of Tom70-dependent preprotein translocation across the outer membrane could be distinguished by BNP (9, 38, 39) . The fungal ADP/ATP carrier belongs to the same conserved family of metabolite carriers as mammalian PiC used in our experiments, and the preproteins have similar targeting pathways (9, 66) . The Tom70-mediated import pathway of a carrier protein was divided into five conceptual stages: stage I, preprotein bound to chaperones in the cytosol; stage II, in complex with Tom70; stage III, translocation across the outer membrane; stage IV, insertion into the inner membrane; and stage V, the final state assembled in the inner membrane (Fig. 6B, lower  panel) . Upon BNP, the completely imported ADP/ATP carrier at stage V was observed as a band at ϳ130 kDa resistant to added protease. The electrochemical potential of the mitochondria was required for insertion of the ADP/ATP carrier into the inner membrane. Upon disruption of the membrane potential, the preprotein accumulated in a distinct ϳ60-kDa outer membrane complex resolved by BNP that was partially sensitive to added protease, corresponding to stage III of import. When external ATP was destroyed along with the membrane potential, the preprotein accumulated in a heterogeneous protease-sensitive 400 -500-kDa complex on the outer membrane, corresponding to stage II (9, 38, 39) . The stage II form was interpreted as preprotein targeted to Tom70, whereas the stage III intermediate represented preprotein translocating across the outer membrane but unable to proceed. The requirement for ATP to progress from stages II to III remains unexplained, but has been postulated to involve cytosolic chaperones (9) .
Although BNP analysis of preprotein import into mammalian mitochondria had not yet been established, it is plausible that the technique could provide information on the translocation step at the outer membrane affected by GA. Under conditions permissive for import, radiolabeled PiC was typically proteolytically cleaved as revealed by SDS-PAGE (Fig. 6B , upper panel, lane 2) and was resolved by BNP as a main band at 130 kDa (middle panel, lane 2, arrow N), with a second band at ϳ100 kDa also visible (arrow Y). Upon addition of external protease, only the cleaved mature form of PiC was predominant (Fig. 6B, upper panel, lane 6) , and the 130-kDa BNP band was largely resistant (middle panel, lane 6). When PiC import was performed after disruption of the inner membrane potential, the appearance of the cleaved mature form was largely abolished (Fig. 6B, upper panel, lane 3) . Although a significant amount of the precursor form was still associated with mitochondria, the precursor was sensitive to external protease and therefore exposed on the outer membrane (Fig. 6B, upper  panel, lane 7) . Upon BNP, the 130-kDa band was no longer visible, but another band at ϳ110 kDa appeared, which was largely digested by external protease (Fig. 6B, middle panel,  lanes 3 and 7, arrow X) . The lower band at ϳ100 kDa was not affected by removal of the membrane potential and thus appeared to be a form nonproductively associated with the membrane. Based on the behavior of the bands, the 130-kDa protease-resistant band was identified as the native or mature form of the protein (stage V). The apparent size of the stage V band was larger than expected for the homodimeric PiC protein and might be due to association of PiC with other proteins such as ANT (70) . The 110-kDa band corresponded to preprotein that had not completely crossed the outer membrane, but was perhaps trapped in the translocation pore. It is possible that this In import reactions with the membrane potential abolished and external ATP removed, association of protease-sensitive PiC with the outer membrane was also observed by SDS-PAGE (Fig. 6B, upper panel, lanes 4 and 8) . The intensity of the 110-kDa intermediate (intermediate X) upon BNP was significantly decreased by ATP removal (Fig. 6B, middle panel, lane 4) . Unlike with yeast mitochondria, high molecular mass complexes of membrane-associated preprotein (stage II) were not reproducibly resolved under these conditions (data not shown). Nevertheless, PiC was associated with the mitochondria to the same extent as in the presence of ATP, and the OMV flotation experiment showed that ATP was not necessary for targeting to the outer membrane (Fig. 6A) . Rather, ATP seemed to be required for the progression from initial membrane targeting to the translocation intermediate X. The relative intensity of the intermediate X band upon BNP was then used as a measure of the amount of preprotein undergoing translocation. In reactions containing ATP but treated with GA, formation of the intermediate was partially but significantly reduced (Fig. 6B , middle panel, lane 5) to ϳ70% of that in reactions without GA ( Table 1 ). Note that there was a significant basal level of intermediate formation even in the absence of ATP (Table 1) , and GA treatment reduced the levels of the intermediate about halfway to the basal level. The total precursor form associated with mitochondria was not affected by GA treatment (Fig. 6B, upper  panel, lane 5 ), in agreement with the OMV targeting experiment (Fig. 6A) . Notably, the reduction in the amount of translocation intermediate X was quantitatively similar to the overall reduction in PiC import caused by GA ( Fig. 2A) and most probably accounted for the full extent of GA inhibition. As expected, NB reduced the overall amount of the precursor form associated with mitochondria, resulting in a corresponding decrease in the amount of intermediate X observed (Table 1 ) (data not shown).
Our results suggest that GA affects preprotein import after outer membrane association and possibly during translocation through the outer membrane. Hsp90 must therefore act in these membrane localized steps, apparently subsequent to docking onto Tom70. We propose that, in addition to its known functions in targeting preproteins to Tom70, Hsp90 remains bound with preprotein to Tom70 on the outer membrane and may furthermore actively assist preprotein translocation. The ATP-dependent chaperone cycle of Hsp90 appears to have a key role in the membrane-associated import function.
DISCUSSION
The two inhibitors used in our study target different regions of Hsp90; and although they both affect overall mitochondrial import of Hsp90-dependent preprotein, their mechanisms are perhaps surprisingly divergent. NB disrupts the maintenance of preprotein in the cytosol by Hsp90 and targeting of preproteinHsp90 complexes onto Tom70. GA revealed that Hsp90-dependent import can be impaired at a later membrane-associated step, apparently related to translocation (Fig. 6B, lower  panel) . These conclusions are directly relevant to understanding the mitochondrial import process and to the potentially therapeutic application of Hsp90 inhibitors.
The model of Hsp90 acting in translocation agrees with the known requirement for cytosolic ATP for import and, moreover, with our current understanding of the biochemical mechanism of Hsp90. In its ATP-bound state, the Hsp90 homodimer adopts a closed conformation with transient contacts between the N-terminal domains of the subunits. Dissociation of substrate from Hsp90 normally involves ATP hydrolysis and most probably reopening of the N-terminal dimerization interface (51) . It has been demonstrated that GA abolishes the ATPdriven dissociation of substrate (48) . In the import process, GAinhibited Hsp90 will be unable to efficiently release preprotein for completion of the translocation step across the outer membrane. It is an additional possibility that, transiently associated with the import pore, Tom70 acts as an anchor point for Hsp90 on the membrane to assist the ATP-regulated transfer of preprotein to the pore.
The presence of Hsp90 in preprotein-Tom70 complexes implies the additional presence of Hsc70 in such complexes. Hsc70, as well as Hsp90, maintains preprotein in the cytosol and docks onto Tom70. Also, inhibition of polypeptide binding by Hsc70 through manipulation of its nucleotide exchange factor Bag-1 interferes with the overall import of preproteins like PiC (9) . There is no reason to expect that Hsc70 is excluded from membrane-associated Tom70 complexes that involve Hsp90. Because combined inhibition of Hsp90 and Hsc70 was found to drastically reduce import efficiency (9), the contribution of Hsc70 to the translocation step might explain the incomplete effect of GA inhibition observed in our assays. Hsc70 in complex with preprotein and Tom70 would have to cycle ATP, which also regulates polypeptide binding by the chaperone, to allow preprotein translocation. For Hsc70, release of bound polypeptide requires exchange of post-hydrolysis ADP for ATP (20) , and it is predicted that inhibition of nucleotide exchange would also impair translocation. At present, pharmacological inhibitors of this step are not yet available.
A function of the chaperones during translocation would fill a gap in our model of the Tom70 import pathway. Tom70 is an elongated monomer with a loosely structured central to C-terminal region that could accommodate preprotein, but without an ATPase or other enzyme activity that could regulate preprotein binding (10, 11) . The components of the Tom40 import pore and Tim9-Tim10 are also nonenzymatic (21, 22, 36) . A model of translocation comprising only Tom70 and the outer membrane import apparatus requires that translocation be driven by successively higher affinities for each step on the pathway. Although this is possible in principle, there are inherent problems with this viewpoint. The import pore itself, consisting of Tom40 and several small proteins, interacts with preproteins (22) , but its affinity must be limited to avoid nonproductive trapping of preproteins in the pore. The high affinity interaction driving translocation must then be with the Tim9-Tim10 complex in the intermembrane space (36) . However, Tim9-Tim10 is not accessible from the cytosolic face of the outer membrane, and preprotein must insert through the pore by random thermal motion to interact with Tim9-Tim10. Such a mechanism would seem rather inefficient. In contrast, our model of translocation suggests an ATP-regulated release of preprotein from chaperone-Tom70 complexes. It is possible that preprotein is held in close proximity to the pore by coordination between the chaperones and Tom70 in transient contact with Tom40. The regulated release of preprotein could direct it to the pore, and preprotein not productively translocated to Tim9-Tim10 could be re-bound by ATP cycling of the chaperones. The extent of coordination between TOM components and the ATPase cycles of Hsp90 and Hsc70 will be the subject of future investigation. The disruption of Hsp90 interactions with both substrate polypeptide and Tom70 by NB suggests that the drug has more than one effect on Hsp90 at the structural level. Tom70 interacts with the C terminus of Hsp90, which contains the terminal MEEVD peptide motif recognized by TPR clamp domains (9, 13) , and the crystal structure of full-length Hsp90 suggests that the motif is normally exposed and unstructured (51) . Substrate polypeptides are thought to bind to the central to C-terminal regions of Hsp90 (40 -42, 47, 51) . NB might sterically block one of these sites as a competitor, but is unlikely to block both sites in this manner. Although it is clear that NB binds primarily the Hsp90 C-terminal region (58) , there is evidence that it causes significant conformational changes in both the C-and N-terminal regions of Hsp90 (60, 61) . It seems most probable that NB targets Hsp90 at or near the substrate-binding site, perhaps sterically displacing substrate in part, but also interfering allosterically with the transient N-terminal dimerization of Hsp90 and reducing accessibility of the C-terminal MEEVD motif. In contrast, the effect of GA on Hsp90 appears consistent with its action through the regulatory ATP-binding domain of the chaperone. Direct interactions of Hsp90 with substrate polypeptide and the TPR domain of Tom70 are not affected, but the ATP-driven polypeptide binding cycle of Hsp90 is blocked. Confirmation of these ideas through structural determination would be significant advances in our understanding of Hsp90 function.
The mechanistic difference between NB and GA has implications for the future development of inhibitors based on these compounds. Although both drugs appear to favor the proteasomal degradation of Hsp90-dependent substrate proteins, they may have differential potencies for various substrates. Because NB disrupts Hsp90 interactions with substrates and co-chaperones more directly, it may shift unfolded polypeptides to other chaperones such as Hsc70, which may then transfer the polypeptides to the degradation machinery. Indeed, for some proteins such as the ErbB2 kinase, dissociation from Hsp90 and increased association of Hsp70 (the inducible form of Hsc70) correlate with degradation of the protein. Although GA and its analogs promote degradation of ErbB2 (50, 71) , NB might prove still more effective. In an opposite case, the von Hippel-Lindau tumor suppressor relies on Hsp90 for its degradation, but not its folding (72) , and NB may actually interfere with its degradation through this pathway. GA, which blocks ATP cycling by Hsp90 and weakens but does not abolish substrate binding, may allow a certain amount of von HippelLindau protein degradation to proceed. Thus, it is possible that one class of Hsp90 inhibitor may have advantages over the other for the clearance of different oncoproteins and in different types of tumor cells. The complex network of protein interactions in which Hsp90 participates (73) , including oncogenic signaling pathways, can be investigated more fully by comparative studies of these Hsp90 inhibitors.
